The global Prostate Cancer Biomarker Market was valued at USD 4.60 billion in 2024 and is projected to reach USD 15.58 billion by 2034, registering a robust CAGR of 13.00% from 2025 to 2034. This impressive expansion is primarily fueled by the rising prevalence of prostate cancer among aging populations globally. According to a December 2024 CDC report, the US recorded 236,659 prostate cancer...
Bangla